Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zepeng Liao

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Entropy (Basel, Switzerland)|June 28, 2023
Combined Gaussian Mixture Model and Pathfinder Algorithm for Data ClusteringHuajuan Huang, Zepeng Liao, Xiuxi Wei, et al.
Bioorganic & Medicinal Chemistry|January 7, 2026
Targeting HPK1 for cancer immunotherapy: An update on recent medicinal chemistry advancesYiyun Song, Zepeng Liao, Xiang Ni, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2025
Discovery of dual PARP/NAMPT inhibitors for the treatment of BRCA wild-type triple-negative breast cancerJie Mao, Kaizhen Wang, Jun Tong, et al.
Journal of Medicinal Chemistry|January 17, 2026
Dual PARP/NAMPT Inhibitors for BRCA Wild-Type Triple-Negative Breast Cancer: Disrupting Homologous Recombination Repair and Activating Antitumor ImmunityKaizhen Wang, Dexiang Wang, Jun Tong, et al.
Journal of Medicinal Chemistry|July 30, 2025
Discovery of a Novel Potent and Orally Efficacious PROTAC Degrader of HPK1 for Tumor ImmunotherapyJun Tong, Kaizhen Wang, Chenyi Liu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Entropy (Basel, Switzerland)|June 28, 2023
Combined Gaussian Mixture Model and Pathfinder Algorithm for Data ClusteringHuajuan Huang, Zepeng Liao, Xiuxi Wei, et al.
Bioorganic & Medicinal Chemistry|January 7, 2026
Targeting HPK1 for cancer immunotherapy: An update on recent medicinal chemistry advancesYiyun Song, Zepeng Liao, Xiang Ni, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2025
Discovery of dual PARP/NAMPT inhibitors for the treatment of BRCA wild-type triple-negative breast cancerJie Mao, Kaizhen Wang, Jun Tong, et al.
Journal of Medicinal Chemistry|January 17, 2026
Dual PARP/NAMPT Inhibitors for BRCA Wild-Type Triple-Negative Breast Cancer: Disrupting Homologous Recombination Repair and Activating Antitumor ImmunityKaizhen Wang, Dexiang Wang, Jun Tong, et al.
Journal of Medicinal Chemistry|July 30, 2025
Discovery of a Novel Potent and Orally Efficacious PROTAC Degrader of HPK1 for Tumor ImmunotherapyJun Tong, Kaizhen Wang, Chenyi Liu, et al.
Pageof 1